Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study. (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.28359
PubMed Identifier: 26597786
Publication URI: http://europepmc.org/abstract/MED/26597786
Type: Journal Article/Review
Volume: 64
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 1
ISSN: 0270-9139